Longitudinal antiretroviral adherence among adolescents infected with human immunodeficiency virus

Archives of Pediatrics and Adolescent Medicine

Volumn 159, Issue 8, 2005, Pages 764-770

  Murphy, Debra A ^a   Belzer, Marvin ^b   Durako, Stephen J ^c   Sarr, Moussa ^c   Wilson, Craig M ^d   Muenz, Larry R ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

^c WESTAT   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS RNA;

ADOLESCENCE; ADOLESCENT; ADOLESCENT DISEASE; ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ARTICLE; CAUCASIAN; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONG TERM CARE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY OF LIFE; RACE DIFFERENCE; RNA VIRUS INFECTION; SCHOOL; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; TIME; UNITED STATES; VALIDATION PROCESS; VIRUS LOAD;

ADOLESCENT; ADOLESCENT BEHAVIOR; ADULT; AGE FACTORS; ALCOHOL DRINKING; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; DEPRESSION; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INTERVIEWS; LONGITUDINAL STUDIES; MALE; MULTIVARIATE ANALYSIS; PATIENT COMPLIANCE; PROPORTIONAL HAZARDS MODELS; RNA, VIRAL; STUDENT DROPOUTS; UNITED STATES; VIRAL LOAD;

EID: 23744444894     PISSN: 10724710     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpedi.159.8.764     Document Type: Article

References (40)

1. Ortiz GM, Nixon DF, Trkola A, et al. HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy. J Clin Invest. 1999;104:R13-R18.
2. Bangsberg DR, Hecht FM, Charlebois ED, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14:357-366.
3. Eldred L. Adherence in the era of protease inhibitors. The Hopkins HIV Report, July 1997. Available at: http://hopkins-aids.edu/publications/report/ jul97_4 .html. Accessed August 11, 2004.
4. Chesney M. Adherence to HAART regimens. AIDS Patient Care STDS. 2003;17:169-177.
5. Singh N, Squier C, Sivek C, Wagener M, Nguyen MH, Yu VL. Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance. AIDS Care. 1996;8:261-269.
6. Kennedy SB. Developing a self-administered tool to predict adherence to antiretroviral therapy: design, method, and objectives. AIDS Patient Care STDS. 2000;14:309-316.
7. Roca B, Gomez CJ, Arnedo A. Adherence, side effects and efficacy of stavudine plus lamivudine plus nelfinavir in treatment-experienced HIV-infected patients. J Infect. 2000;41:50-54.
8. Roca B, Gomez CJ, Arnedo A. A randomized, comparative study of lamivudine plus stavudine, with indinavir or nelfinavir, in treatment-experienced HIV-infected patients. AIDS. 2000;14:157-161.
9. Murphy DA, Greenwell L, Hoffman D. Factors associated with antiretroviral adherence among HIV-infected women with children. Women Health. 2002;36:97-111.
10. Murphy DA, Roberts KJ, Hoffman D, Molina A, Lu MC. Barriers and successful strategies to antiretroviral adherence among HIV-infected monolingual Spanishspeaking patients. AIDS Care. 2003;15:217-230.
11. Murphy DA, Roberts KJ, Martin DJ, Marelich W, Hoffman D. Barriers to antiretroviral adherence among HIV-infected adults. AIDS Patient Care STDS. 2000;14:47-58.
12. Murphy DA, Wilson CM, Durako SJ, Muenz LR, Belzer M. Antiretroviral medication adherence among the REACH HIV-infected adolescent cohort. AIDS Care. 2001;13:27-40.
13. Samet JH, Libman H, Steger KA, et al. Compliance with zidovudine therapy in patients infected with human immunodeficiency virus type 1: a cross-sectional study in a municipal hospital clinic. Am J Med. 1992;92:495-502.
14. Balestra P, Ferri F, Galgani S, et al. Clinical, psychological, and behavioral characteristics of HIV patients reporting low compliance to treatments. Paper presented at: International Conference on AIDS; July 7-12, 1996; Vancouver, British Columbia.
15. Chesney MA. Factors affecting adherence to antiretroviral therapy. Clin Infect Dis. 2000;30(suppl 2):S171-S176.
16. Chow R, Chin T, Fong IW, Bendayan R. Medication use patterns in HIV-positive patients. Can J Hosp Pharm. 1993;46:171-175.
17. Deeks SG, Loftus R, Cohen P, Chin S, Grant R. Incidence and predictors of virological failure of indinavir and/or ritonavir in an urban health clinic. Paper presented at: 37th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 1997; Toronto, Ontario.
18. Rogers AS, Futterman DK, Moscicki AB, Wilson CM, Ellenberg J, Vermund SH. The REACH Project of the Adolescent Medicine HIV/AIDS Research Network: design, methods, and selected characteristics of participants. J Adolesc Health. 1998;22:300-311.
19. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385-401.
20. Garrison CZ, Addy CL, Jackson KL, et al. The CES-D as a screen for depression and other psychiatric disorders in adolescents. J Am Acad Child Adolesc Psychiatry. 1991;30:636-641.
21. Lewinsohn PM, Rohde P, Seeley JR. Major depressive disorder in older adolescents: prevalence, risk factors, and clinical implications. Clin Psychol Rev. 1998;18:765-794.
22. Murphy DA, Durako SJ, Moscicki AB, et al. No change in health risk behaviors over time among HIV infected adolescents in care: role of psychological distress. J Adolesc Health. 2001;29(suppl):57-63.
23. Reynolds CR, Richmond BO. What I think and feel: a revised measure of children's manifest anxiety. J Abnorm Child Psychol. 1978;6:271-280.
24. Castaneda A, McCandless B, Palermo D. The children's form of the manifest anxiety scale. Child Dev. 1956;27:317-326.
25. Reynolds CR, Richmond BO. Revised Children's Manifest Anxiety Scale. Los Angeles, Calif: Western Psychological Services; 1985.
26. Murphy DA, Rotheram MJ, Marelich WD. Factor structure of a coping scale across two samples. J Appl Soc Psychol. 2003;33:627-647.
27. Ewing JA. Detecting alcoholism: the CAGE questionnaire. JAMA. 1984;252:1905-1907.
28. Hays RD, Sherbourne CD, Mazel RM. The RAND 36-Item Health Survey 1.0. Santa Monica, Calif: RAND; 1993. Document No. RP-247.
29. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbidity and Mortality Weekly Report. 1992;41(RR-17):1-19.
30. Diggle PJ, Liang KY, Zegler SL. Analysis of Longitudinal Data. Oxford, England: Clarendon Press; 1994.
31. Stokes ME, Davis CS, Koch GG. Categorical Data Analysis Using the SAS System. Cary, NC: SAS Institute Inc; 1995.
32. Allison PD. Survival Analysis Using the SAS system: A Practical Guide. Cary, NC: SAS Institute Inc; 1995.
33. Reynolds WM. Depression in adolescents: contemporary issues and perspectives. Advances in Clinical Child Psychology. 1994;16:261-316.
34. Petersen AC, Compas BE, Brooks-Gunn J, Stemmler M, Ey S, Grant KE. Depression in adolescence. Am Psychol. 1993;48:155-168.
35. March J, Silva S, Petrycki S, et al. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA. 2004;292:807-820.
36. Kleiger JH, Dirks JF. Medication compliance in chronic asthmatic patients. J Asthma Res. 1979;16:93-96.
37. Litt IF. Know thyself: adolescents' self-assessment of compliance behavior. Pediatrics. 1985;75:693-696.
38. Tamaroff MH, Festa RS, Adesman AR, Walco GA. Therapeutic adherence to oral medication regimens by adolescents with cancer. II. Clinical and psychologic correlates. J Pediatr. 1992;120:812-817.
39. Tebbi CK. Treatment compliance in childhood and adolescence. Cancer. 1993;71:3441-3449.
40. Murphy DA, Durako S, Muenz LR, Wilson CM. Marijuana use among HIV+ and high-risk adolescents: a comparison of self-report through audio computerassisted self-administered interviewing and urinalysis. Am J Epidemiol. 2000;152:805-813.